{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:24:18Z","timestamp":1791397458311,"version":"4.3.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijpharm.2023.123746","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T19:45:12Z","timestamp":1703360712000},"page":"123746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: An insight into QbD driven optimization, in vitro characterization, and pharmacodynamics"],"prefix":"10.1016","volume":"650","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4115-5343","authenticated-orcid":false,"given":"Uddhav S.","family":"Bagul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7980-5687","authenticated-orcid":false,"given":"Mayuri V.","family":"Nazirkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham V.","family":"Khot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0723-5588","authenticated-orcid":false,"given":"Amol A.","family":"Tagalpallewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakant R.","family":"Kokare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijpharm.2023.123746_b0005","doi-asserted-by":"crossref","DOI":"10.1007\/s12247-019-09418-z","article-title":"Full factorial design, optimization, in vitro and ex vivo studies of ocular timolol-loaded microsponges","volume":"15","author":"Abd-Elal","year":"2020","journal-title":"Journal of Pharmaceutical Innovation"},{"issue":"10","key":"10.1016\/j.ijpharm.2023.123746_b0010","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3390\/pharmaceutics14102215","article-title":"Sertaconazole-nitrate-loaded leciplex for treating keratomycosis: optimization using D-optimal design and in vitro, ex vivo, and in vivo studies","volume":"14","author":"Abdellatif","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ijpharm.2023.123746_b0015","article-title":"Epidemiology of glaucoma: the past, present, and predictions for the future","volume":"12","author":"Allison","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ijpharm.2023.123746_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114342","article-title":"Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies. In","volume":"187","author":"Alshaikh","year":"2022","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/j.ijpharm.2023.123746_b0025","article-title":"Design and optimization of topical terbinafine hydrochloride nanosponges: Application of full factorial design, in vitro and in vivo evaluation","volume":"11","author":"Amer","year":"2020","journal-title":"Journal of Advanced Pharmaceutical Technology and Research"},{"key":"10.1016\/j.ijpharm.2023.123746_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2016.03.011","article-title":"Influence of hydroxypropylmethylcellulose and poloxamer composite on developed ophthalmic in situ gel: Ex vivo and in vivo characterization","volume":"33","author":"Barse","year":"2016","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"2","key":"10.1016\/j.ijpharm.2023.123746_b0035","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-019-00697-0","article-title":"Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide","volume":"10","author":"Bhalerao","year":"2020","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/j.ijpharm.2023.123746_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2022.09.008","article-title":"Mucoadhesive brinzolamide-loaded nanofibers for alternative glaucoma treatment","volume":"180","author":"Cegielska","year":"2022","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"6","key":"10.1016\/j.ijpharm.2023.123746_b0045","doi-asserted-by":"crossref","DOI":"10.1111\/jcpt.13609","article-title":"Efficacy of brinzolamide in the initial management of acute primary angle closure: A randomized controlled trial","volume":"47","author":"Chen","year":"2022","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.ijpharm.2023.123746_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2019.10.219","article-title":"Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study","volume":"152","author":"Dubey","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.ijpharm.2023.123746_b0055","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.2147\/IJN.S268208","article-title":"Ocular inserts of voriconazole-loaded proniosomal gels: formulation, evaluation and microbiological studies","author":"El-Emam","year":"2020","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.ijpharm.2023.123746_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122372","article-title":"Nose-to-brain delivery of octreotide acetate in situ gel for pituitary adenoma: Pharmacological and in vitro cytotoxicity studies","volume":"629","author":"Gadhave","year":"2022","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2023.123746_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2017.09.004","article-title":"Formulation, in vitro and in vivo evaluation of celecoxib nanosponge hydrogels for topical application","volume":"41","author":"Gangadharappa","year":"2017","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.ijpharm.2023.123746_b0070","doi-asserted-by":"crossref","unstructured":"Gupta, N., & Y\u00fccel, Y. H. 2007. Glaucoma as a neurodegenerative disease. In Current Opinion in Ophthalmology (Vol. 18, Issue 2). https:\/\/doi.org\/10.1097\/ICU.0b013e3280895aea.","DOI":"10.1097\/ICU.0b013e3280895aea"},{"key":"10.1016\/j.ijpharm.2023.123746_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.103004","article-title":"Formulation and evaluation of brinzolamide encapsulated niosomal in-situ gel for sustained reduction of IOP in rabbits","volume":"67","author":"Gupta","year":"2022","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.ijpharm.2023.123746_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2020.01.057","article-title":"Advances and limitations of drug delivery systems formulated as eye drops. In","volume":"321","author":"Jumelle","year":"2020","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ijpharm.2023.123746_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101943","article-title":"Design, evaluation and bioavailability of oxybutynin chloride nanosponges on healthy human volunteers","volume":"60","author":"Kassem","year":"2020","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"1","key":"10.1016\/j.ijpharm.2023.123746_b0090","article-title":"In situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucoma","volume":"102","author":"Katiyar","year":"2014","journal-title":"Carbohydrate Polymers"},{"issue":"12","key":"10.1016\/j.ijpharm.2023.123746_b0095","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-022-01155-0","article-title":"Gellan gum\u2013based in situ gelling ophthalmic nanosuspension of Posaconazole","volume":"12","author":"Khare","year":"2022","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/j.ijpharm.2023.123746_b0100","doi-asserted-by":"crossref","unstructured":"Khiev, D., Mohamed, Z. A., Vichare, R., Paulson, R., Bhatia, S., Mohapatra, S., Lobo, G. P., Valapala, M., Kerur, N., Passaglia, C. L., Mohapatra, S. S., & Biswal, M. R. (2021). Emerging nano-formulations and nanomedicines applications for ocular drug delivery. In Nanomaterials (Vol. 11, Issue 1). https:\/\/doi.org\/10.3390\/nano11010173.","DOI":"10.3390\/nano11010173"},{"issue":"6","key":"10.1016\/j.ijpharm.2023.123746_b0105","doi-asserted-by":"crossref","DOI":"10.1080\/10915810802656996","article-title":"Hen egg chorioallantoic membrane bioassay: An in vitro alternative to draize eye irritation test for pesticide screening","volume":"27","author":"Kishore","year":"2008","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.ijpharm.2023.123746_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119499","article-title":"Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting","volume":"586","author":"Kumbhar","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijpharm.2023.123746_b0115","article-title":"A review on poloxamer and hydroxy propyl methyl cellulose combination as thermoresponsive polymers in novel ophthalmic in situ gel formulation and their characterization","volume":"13","author":"Kurniawansyah","year":"2021","journal-title":"International Journal of Applied Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2023.123746_b0120","doi-asserted-by":"crossref","unstructured":"Li, X., Nie, S. fang, Kong, J., Li, N., Ju, C. yi, & Pan, W. san. (2008). A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. International Journal of Pharmaceutics, 363(1\u20132). https:\/\/doi.org\/10.1016\/j.ijpharm.2008.07.017.","DOI":"10.1016\/j.ijpharm.2008.07.017"},{"issue":"3","key":"10.1016\/j.ijpharm.2023.123746_b0125","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-015-0382-1","article-title":"Liposomes as a Novel Ocular Delivery System for Brinzolamide. In Vitro and In Vivo Studies","volume":"17","author":"Li","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.ijpharm.2023.123746_b0130","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/jcm12051828","article-title":"The Global Burden of Glaucoma: Findings from the Global Burden of Disease 2019 Study and Predictions by Bayesian Age\u2013Period\u2013Cohort Analysis","volume":"12","author":"Lin","year":"2023","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"10.1016\/j.ijpharm.2023.123746_b0135","article-title":"Thermosensitive brinzolamide in situ gel nanoemulsions, in vitro and ex vivo evaluation","volume":"11","author":"Mahboobian","year":"2021","journal-title":"Biointerface Research in Applied Chemistry"},{"key":"10.1016\/j.ijpharm.2023.123746_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112255","article-title":"Formulation and development of tacrolimus-gellan gum nanoformulation for treatment of dry eye disease","volume":"211","author":"Modi","year":"2022","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2023.123746_b0145","article-title":"Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery","volume":"506","author":"Morsi","year":"2016","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijpharm.2023.123746_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-5173(99)00265-3","article-title":"Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery","volume":"190","author":"Nagarsenker","year":"1999","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2023.123746_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-021-00186-7","article-title":"Determination of residual solvents in paclitaxel by headspace gas chromatography","volume":"7","author":"Noorbasha","year":"2021","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"7","key":"10.1016\/j.ijpharm.2023.123746_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2018.01.005","article-title":"Ocular administration of acetazolamide microsponges in situ gel formulations","volume":"26","author":"Obiedallah","year":"2018","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/j.ijpharm.2023.123746_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120623","article-title":"Thermosensitive and mucoadhesive in situ ocular gel for effective local delivery and antifungal activity of itraconazole nanocrystal in the treatment of fungal keratitis","volume":"602","author":"Permana","year":"2021","journal-title":"International Journal of Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijpharm.2023.123746_b0170","doi-asserted-by":"crossref","DOI":"10.55522\/jmpas.V11I2.2586","article-title":"Fabrication and evaluation of nanosponges of besifloxacin hydrochloride for ocular drug delivery","volume":"11","author":"Pillai","year":"2022","journal-title":"Journal of Medical Pharmaceutical and Allied Sciences"},{"key":"10.1016\/j.ijpharm.2023.123746_b0175","doi-asserted-by":"crossref","unstructured":"Prabhu, P. P., Prathvi, Gujaran, T. V., Mehta, C. H., Suresh, A., Koteshwara, K. B., Pai, K. G., & Nayak, U. Y. 2021. Development of lapatinib nanosponges for enhancing bioavailability. Journal of Drug Delivery Science and Technology, 65. https:\/\/doi.org\/10.1016\/j.jddst.2021.102684.","DOI":"10.1016\/j.jddst.2021.102684"},{"issue":"10","key":"10.1016\/j.ijpharm.2023.123746_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2016.06.023","article-title":"Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide","volume":"105","author":"Quinteros","year":"2016","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ijpharm.2023.123746_b0185","doi-asserted-by":"crossref","DOI":"10.1177\/2280800020942712","article-title":"Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma","volume":"18","author":"Song","year":"2020","journal-title":"Journal of Applied Biomaterials and Functional Materials"},{"issue":"3","key":"10.1016\/j.ijpharm.2023.123746_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jobcr.2019.04.001","article-title":"Development of Moxifloxacin Hydrochloride loaded in-situ gel for the treatment of periodontitis: In-vitro drug release study and antibacterial activity","volume":"9","author":"Swain","year":"2019","journal-title":"Journal of Oral Biology and Craniofacial Research"},{"key":"10.1016\/j.ijpharm.2023.123746_b0195","doi-asserted-by":"crossref","unstructured":"Swaminathan, S., Cavalli, R., & Trotta, F. 2016b. Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development. In Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (Vol. 8, Issue 4). https:\/\/doi.org\/10.1002\/wnan.1384.","DOI":"10.1002\/wnan.1384"},{"issue":"6","key":"10.1016\/j.ijpharm.2023.123746_b0200","doi-asserted-by":"crossref","DOI":"10.1166\/jbn.2013.1594","article-title":"Nanosponges encapsulating dexamethasone for ocular delivery: Formulation design, physicochemical characterization, safety and corneal permeability assessment","volume":"9","author":"Swaminathan","year":"2013","journal-title":"Journal of Biomedical Nanotechnology"},{"issue":"4","key":"10.1016\/j.ijpharm.2023.123746_b0205","doi-asserted-by":"crossref","DOI":"10.1093\/toxres\/tfaa066","article-title":"Investigating the ocular toxicity potential and therapeutic efficiency of in situ gel nanoemulsion formulations of brinzolamide","volume":"9","author":"Talaei","year":"2020","journal-title":"Toxicology Research"},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2023.123746_b0215","article-title":"Brinzolamide nanocrystal formulations for ophthalmic delivery: Reduction of elevated intraocular pressure in vivo","volume":"467","author":"Tuomela","year":"2014","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2023.123746_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2022.02.010","article-title":"Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery","volume":"172","author":"Varela-Fern\u00e1ndez","year":"2022","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"3","key":"10.1016\/j.ijpharm.2023.123746_b0225","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-013-9997-2","article-title":"Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: In vitro and in vivo evaluation","volume":"14","author":"Wu","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.ijpharm.2023.123746_b0230","doi-asserted-by":"crossref","DOI":"10.1177\/147323000903700322","article-title":"Influence of borneol on in vitro corneal permeability and on in vivo and in vitro corneal toxicity","volume":"37","author":"Yang","year":"2009","journal-title":"Journal of International Medical Research"},{"key":"10.1016\/j.ijpharm.2023.123746_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118943","article-title":"Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery","volume":"575","author":"Yu","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2023.123746_b0240","article-title":"Nanocrystals technology for improving bioavailability of poorly soluble drugs: A mini-review. In","volume":"Vol. 17, Issue 1","author":"Zhou","year":"2017","journal-title":"Journal of Nanoscience and Nanotechnology"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517323011687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517323011687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:48:33Z","timestamp":1736383713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517323011687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":47,"alternative-id":["S0378517323011687"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123746","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: An insight into QbD driven optimization, in vitro characterization, and pharmacodynamics","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123746"}}